文献速递乳房整形与再造

乳房假体冲洗液疗效的体外模型比较分析

The Efficacy of Breast Implant Irrigant Solutions: A Comparative Analysis Using an In Vitro Model.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

该体外研究用光滑硅胶假体盘比较了10%聚维酮碘、Clorpactin、Prontosan、三联抗生素溶液与生理盐水对耐甲氧西林金黄色葡萄球菌和表皮葡萄球菌的冲洗效果,发现聚维酮碘对全部四株菌的细菌负荷降低幅度最大,Clorpactin、三联抗生素溶液与Prontosan效果相近。

要点

  • 聚维酮碘对四株MRSA与表皮葡萄球菌的细菌负荷降低幅度最大。
  • Prontosan对除一株MRSA外其余菌株均有10倍细菌计数下降。
  • Clorpactin仅对一株表皮葡萄球菌降低回收菌落形成单位。

核心结论

  • 聚维酮碘是减少MRSA和表皮葡萄球菌污染最有效的冲洗液。
  • 鉴于美国FDA近期解除禁令,有必要开展更大规模的聚维酮碘作为乳房假体冲洗液的临床研究。

研究设计与样本

  • 体外模型研究:将无菌光滑硅胶假体盘浸入冲洗液后,在MRSA或表皮葡萄球菌悬液中过夜孵育。
  • 测试冲洗液包括10%聚维酮碘、Clorpactin、Prontosan、三联抗生素溶液和生理盐水(阴性对照)。
  • 每种细菌测试两株菌株,冲洗后经漂洗和超声处理置换黏附细菌并定量,计算归一化值以表征相对效力。

主要发现

  • 聚维酮碘使所有菌株的细菌负荷降低10的10次方倍。
  • Prontosan处理的假体盘除一株MRSA外,其余菌株细菌计数均下降10倍。
  • 与Prontosan相比,三联抗生素溶液对MRSA细菌负荷降低呈更强趋势,但对表皮葡萄球菌活性较弱。
  • Clorpactin仅对一株表皮葡萄球菌降低回收的菌落形成单位。
  • 聚维酮碘对全部四株菌效力最大,但Clorpactin、三联抗生素溶液和Prontosan效力相似。

关键数值与推荐

  • 聚维酮碘对全部四株菌的细菌负荷降低10的10次方倍。
  • Prontosan对除一株MRSA外其余菌株细菌计数下降10倍。

临床怎么用

  • 体外证据支持聚维酮碘在假体置入时作为冲洗液具有最强抗菌效力。
  • 临床选择冲洗液时可参考本体外相对效力数据,但需结合临床研究进一步验证。

局限性

  • 证据等级为治疗性V级。
  • 研究为体外模型,结论需更大规模临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infections are challenging complications of implant-based breast reconstruction and augmentation. They pose a clinical challenge, with significant economic implications. One proposed solution is implant irrigation at the time of placement. There is no consensus on the optimal irrigant solution. METHODS: The authors tested the relative efficacy of 10% povidone-iodine, Clorpactin, Prontosan, triple-antibiotic solution, or normal saline (negative control) against two strains each of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Sterile, smooth silicone implant disks were immersed in irrigant solution, then incubated in suspensions of methicillin-resistant S. aureus or S. epidermidis overnight. The disks were rinsed and sonicated to displace adherent bacteria from the implant surface, and the displaced bacteria were quantified. Normalized values were calculated to characterize the relative efficacy of each irrigant. RESULTS: Povidone-iodine resulted in reductions of the bacterial load by a factor of 10 to 10 for all strains. Prontosan-treated smooth breast implant disks had a 10-fold reduction in bacterial counts for all but one methicillin-resistant S. aureus strain. In comparison to Prontosan, triple-antibiotic solution demonstrated a trend of greater reduction in methicillin-resistant S. aureus bacterial load and weaker activity against S. epidermidis strains. Clorpactin reduced the recovered colony-forming units for only a single strain of S. epidermidis. Povidone-iodine demonstrated the greatest efficacy against all four strains. However, Clorpactin, triple-antibiotic solution, and Prontosan demonstrated similar efficacies. CONCLUSIONS: Povidone-iodine was the most efficacious of the irrigants at reducing methicillin-resistant S. aureus and S. epidermidis contamination. Given the recent lifting of the U.S. Food and Drug Administration moratorium, larger clinical studies of povidone-iodine as a breast implant irrigant solution are warranted. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Ngaage LM, Elegbede A, Brao K, et al. The Efficacy of Breast Implant Irrigant Solutions: A Comparative Analysis Using an In Vitro Model. Plast Reconstr Surg. 2020. PMID: 32740580. doi:10.1097/PRS.0000000000007028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。